Janet Woodcock

Selected news for the person - Janet Woodcock, collected since 4/2019. Recent stories appear in biopharmadive.com and Washington Examiner. This person shares healthcare news with Food and Drug Administration, Center for Drug Evaluation and Research, COVID-19 Vaccine, COVID-19 and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
4/24/2021 Johnson & Johnson COVID vaccine: Pause lifted by FDA, use to resume Des Moines Register ... distribution of the J&J vaccine to resume."Both agencies have full confidence that this vaccine's known and potential benefits outweigh its known and potential risks in individuals 18 years and older," said Dr. Janet Woodcock , the FDA's acting commissioner.The J&J vaccine should be available almost immediately, "by tomorrow morning even," said Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.Everyone who receives ...
4/23/2021 Health Officials: Johnson & Johnson Vaccinations Could Restart Soon Yahoo News ... blood-clotting disorder was discovered in six recipients of the vaccine, out of a total of 7 million recipients. Officials have since searched for additional cases of the clotting disorder.Acting FDA commissioner Dr. Janet Woodcock said that while a small number of cases were discovered, the rate of the clotting disorder was not higher “in terms of the order of magnitude” even with the new cases.“We’ve ...
4/23/2021 US health panel reviews J&J vaccine pause over rare clots | WGN Radio 720 - Chicago's Very Own wgnradio.com ... updated online vaccine information leaflets for would-be recipients and health workers, so that shots could resume as early as Saturday.“This is not a decision the agencies reached lightly,” FDA Acting Commissioner Janet Woodcock told reporters late Friday.CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that we ...
4/23/2021 US health panel reviews J&J vaccine pause over rare clots wcax.com ... updated online vaccine information leaflets for would-be recipients and health workers, so that shots could resume as early as Saturday.“This is not a decision the agencies reached lightly,” FDA Acting Commissioner Janet Woodcock told reporters late Friday.CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that we ...
4/23/2021 US health panel reviews J&J vaccine pause over rare clots hawaiinewsnow.com ... updated online vaccine information leaflets for would-be recipients and health workers, so that shots could resume as early as Saturday.“This is not a decision the agencies reached lightly,” FDA Acting Commissioner Janet Woodcock told reporters late Friday.CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that we ...
4/23/2021 US health panel reviews J&J vaccine pause over rare clots 13abc.com ... updated online vaccine information leaflets for would-be recipients and health workers, so that shots could resume as early as Saturday.“This is not a decision the agencies reached lightly,” FDA Acting Commissioner Janet Woodcock told reporters late Friday.CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that we find ...
4/23/2021 Guidance on Johnson & Johnson's COVID-19 vaccine expected from U.S. health panel after pause over rare clots Chicago Tribune ... online vaccine information leaflets for would-be recipients and health workers, so that shots could resume as early as Saturday.Advertisement “This is not a decision the agencies reached lightly,” FDA Acting Commissioner Janet Woodcock told reporters late Friday.CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that we ...
4/23/2021 FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 Vaccines chemdiv.com ... Authorized COVID-19 Vaccines Previous Post FDA Continues Important Steps to Ensure Quality, Safety and Effectiveness of Authorized COVID-19 VaccinesStatement From: Acting Commissioner of Food and Drugs – Food and Drug Administration Janet Woodcock M.D. Director – Center for Biologics Evaluation and Research (CBER) Peter Marks M.D., PhD.The U.S. Food and Drug Administration takes its responsibility to ensure medical product quality, safety and effectiveness very seriously. The ...
4/23/2021 US health panel reviews J&J vaccine pause over rare clots myplainview.com ... updated online vaccine information leaflets for would-be recipients and health workers, so that shots could resume as early as Saturday.“This is not a decision the agencies reached lightly,” FDA Acting Commissioner Janet Woodcock told reporters late Friday.CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that we ...
4/23/2021 Coronavirus: CDC advisory panel meeting Friday to discuss Johnson & Johnson vaccine hot105fm.com ... vaccine.“We have concluded that the known and potential benefits of the Janssen COVID-19 Vaccine outweigh its known and potential risks in individuals 18 years of age and older,” acting FDA Commissioner Janet Woodcock said in a statement. “We are confident that this vaccine continues to meet our standards for safety, effectiveness and quality. We recommend people with questions about which vaccine is right for them have those ...
4/23/2021 Johnson & Johnson's COVID-19 vaccine, on pause for 10 days, appears poised for another green light FiercePharma ... few additional cases have been reported. The FDA declined to divulge how many to the New York Times.“We’ve now received more cases, but it isn’t an avalanche,” FDA acting director Janet Woodcock said on Thursday. “We’re not seeing a big surge, which is a great relief.”When the FDA ordered the pause on April 13, Woodcock said she expected it to last a “matter ...
4/23/2021 Coronavirus: CDC advisory panel meeting Friday to discuss Johnson & Johnson vaccine – FOX13 News Memphis fox13memphis.com ... vaccine.“We have concluded that the known and potential benefits of the Janssen COVID-19 Vaccine outweigh its known and potential risks in individuals 18 years of age and older,” acting FDA Commissioner Janet Woodcock said in a statement. “We are confident that this vaccine continues to meet our standards for safety, effectiveness and quality. We recommend people with questions about which vaccine is right for them have those ...
4/23/2021 US health panel reviews J&J vaccine pause over rare clots | RochesterFirst rochesterfirst.com ... updated online vaccine information leaflets for would-be recipients and health workers, so that shots could resume as early as Saturday.“This is not a decision the agencies reached lightly,” FDA Acting Commissioner Janet Woodcock told reporters late Friday.CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that we ...
4/23/2021 Advocacy Group Petitions FDA to Consider Revoking Remdesivir Approval fdanews.com ... Äôs previous failure to convene its own public advisory committee to consider whether to approve remdesivir was inexcusable,‚Äù said Michael Abrams, lead author of a letter sent by the group to Acting Commissioner Janet Woodcock and Patrizia Cavazzoni, director of the FDA‚Äôs Center for Drug Evaluation and Research.‚ÄúThis failure is particularly troubling given that the agency was aware of evidence from a major clinical trial that raised ...
4/23/2021 LIVE: US health panel reviews J&J vaccine pause over rare clots walb.com ... updated online vaccine information leaflets for would-be recipients and health workers, so that shots could resume as early as Saturday.“This is not a decision the agencies reached lightly,” FDA Acting Commissioner Janet Woodcock told reporters late Friday.CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that we ...
4/23/2021 Johnson & Johnson Coronavirus Vaccine Rollout Resumes Business Insider The US will resume using Johnson & Johnson's coronavirus vaccine. The decision came after a CDC committee voted to recommend using the shots. The US paused its rollout on April 13, citing concerns over rare blood clots. See more stories on Insider's business page . The US will resume using Johnson & Johnson's COVID-19 vaccine, more than a week after regulators paused the rollout to investigate reports of rare but serious side ...
4/22/2021 Vaccination campaign slows in past week Washington Examiner ... store than the two-shot Pfizer and Moderna vaccines. While reports of clotting are rare, the Biden administration acted out of an “abundance of caution,” according to acting Food and Drug Administration Commissioner Janet Woodcock .BIDEN SAYS CORONAVIRUS DEATHS AMONG SENIORS ARE DOWN 80% AS HE LAUNCHES NEW VACCINATION PHASEThe single-shot vaccine was also crucial to getting shots into the arms of people who are homebound, live ...
4/21/2021 FDA Finds Poor Conditions at Contractor's Plant for Making J&J's Covid-19 Vaccine The Wall Street Journal ... it is released for potential distribution, the FDA said.“We will not allow the release of any product until we feel confident that it meets our expectations for quality,” said FDA Acting Commissioner Janet Woodcock and Peter Marks, who heads the FDA department overseeing vaccines.The Emergent plant recently had a contamination-related mishap that ruined a batch of the main ingredient for J&J’s Covid-19 vaccine ...
4/20/2021 Inoculating the Government - WSJ The Wall Street Journal ... which uses similar technology.The agencies said the pause was necessary to notify health-care providers how to treat the unusual clots and give regulators time to review cases. Fair enough. FDA Acting Commissioner Janet Woodcock said the pause would only be days, and the White House assured the public it wouldn't frustrate vaccinations. That’s not what happened.The CDC convened a meeting of its Advisory Committee on Immunization ...
4/19/2021 White House Considering Minority Candidates for FDA Commissioner | 2021-04-16 | CenterWatch centerwatch.com The White House has reportedly broadened its potential picks for permanent FDA commissioner to include several minority women.Besides current acting commissioner Janet Woodcock , who is White, President Biden is believed to be considering a list of women of various ethnic backgrounds, including: Former Chinese-American FDA official, Florence Houn, who worked with the agency for 14 years in senior positions related to vaccine research and review and drug evaluations ...